For nearly 20 years, Denis has specialized in the development of health economic models, and he has worked in numerous therapeutic areas including Alzheimer’s disease, infectious diseases, diabetes, cardiovascular disease, obesity, and smoking cessation. He has experience in discrete event simulation, Markov modeling, Monte Carlo simulations, survival partition analysis, and other innovative techniques for assessing the health and economic impact of medical technologies.
Prior to Evidera, he was a senior health economist with Caro Research where he specialized in cost-effectiveness and other economic modeling studies. Denis studied economics at Concordia University in Montreal and community health and epidemiology at Dalhousie University in Halifax. He has also held analyst positions at the Royal Bank of Canada, Health Canada, Human Resources Development Canada, and Transport Canada.
Denis has co-authored numerous publications and presented at both national and international conferences. He has published in peer-reviewed journals such as Neurology, Value in Health, Pharmacoeconomics, PLoS ONE and Clinical Therapeutics and has also co-authored a number of review papers in the area of pharmacoeconomics. Additionally, he has served as a reviewer for multiple leading industry journals, including Applied Health Economics & Health Policy, Expert Review of Pharmacoeconomics & Outcomes Research, Pharmacoeconomics, Drugs, Clinical Drug Investigation, and the American Journal of Geriatric Pharmacotherapy.